Aardvark Therapeutics, Inc.
AARD
$8.69
-$0.66-7.06%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.18M | -3.81M | -3.81M | -2.04M | -2.11M |
| Total Depreciation and Amortization | 87.00K | 25.00K | 25.00K | 25.00K | 26.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 236.00K | 159.00K | 159.00K | 166.00K | 814.00K |
| Change in Net Operating Assets | -96.00K | 427.00K | 427.00K | 694.00K | -316.00K |
| Cash from Operations | -3.96M | -3.20M | -3.20M | -1.16M | -1.59M |
| Capital Expenditure | -5.00K | -49.00K | -49.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.00K | -49.00K | -49.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 169.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 42.50M | 42.50M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.00K | -1.03M | -1.03M | -- | -- |
| Cash from Financing | 64.00K | 41.47M | 41.47M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.90M | 38.22M | 38.22M | -1.16M | -1.59M |
